Clinical trial for Diabetes
Official title Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
ClinicalTrials.gov ID: NCT05734313
What this study is testing
- What it's testing
- The study will see if the therapy can reduce anxiety and depression and help control blood sugar levels.
- Who it's for
- Adults who have type 1 diabetes.
- What's involved
- Participants will have online CBT sessions and review of their continuous glucose monitor data.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Type 1 diabetes (T1D) duration ≥ 6 months
- 18-64 years old
- English- or Spanish-speaking
- Anxiety or depressive mood disorder as per structured diagnostic interview.
You likely can't join if
- Developmental or sensory disability interfering with participation
- Current pregnancy
- Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
- Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
- Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
- The Bronx, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States; The Bronx, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.